Further, a combination of hesperidin (100 mg/kg) with coenzyme Q10 (40 mg/kg) did not produce any significant protective effect on hyper locomotor activity on days 7 and 14 and hypolocomotor activity on day 21 as compared to their effect per se in ketamine-treated animals
Importantly, all these benefits were mainly attributed to the LDL lowering effect of statin therapy (Beltrn Romero et al
Previous research has already demonstrated the ability of AOX administration to impede the advancement of neurodegenerative diseases
Tong J, Ang L-C, Williams B, Furukawa Y, Fitzmaurice P, Guttman M, Boileau I, Hornykiewicz O, Kish SJ
These compounds do not work through the same pathways